CClinicalTrials.gg
CompletedNCT02797353SRCUpdated Jun 22, 2020

Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan

An interventional study of Maternal Neonatal and Child Health Interventions in Antepartum Hemorrhage, Postpartum Hemorrhage and Anemia, sponsored by Aga Khan University. Completed. Open to participants aged 1 Day to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-22.

Sponsored by Aga Khan University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
15,000
Allocation
Non-randomized
Ages
1 Day to 49 Years
Sex
All
01

Study summary

The Maternal Neonatal and Child health indicators in District Dadu of Pakistan portrays a dismal pictures and after the floods of 2010-2011 the health infrastructure of this district was badly affected. Aga Khan University Pakistan is intending to implement a service delivery project for the improvement of Maternal Neonatal and Child health situation through evidence based MNCH interventions.

Read the detailed description

The Aga Khan University is implementing together with its local partners a MNCH project in five Union Councils (UC) in Dadu District in Sindh Province. The project will scale up the already existing health services for MNCH in the district referral hospital and the five Basic Health Units (BHUs), one in each UC. Institutional based services as well as their scope for outreach to pregnant women, mothers and children in the communities with the aim to promote safe deliveries as per WHO guidelines and Government policy will be enhanced. In order to deliver quality services, the facilities will be renovated and equipped and the capacity of the existing staff will be strengthened through different training courses in MNCH. In addition professionally trained Lady Health Visitors will be introduced in the BHUs, who will conduct all maternal services including deliveries in the BHU and the communities. The health staff is furthermore responsible to establish and facilitate community support groups and raise communal awareness for the importance of mother and child health care as well as safe deliveries with skilled attendants. Operational research is an integral part of this pilot project. The research validates the progress and improvement of maternal and child health indicators. The results will be used to lobby the scale up of MNCH interventions with the Ministry of Health in Pakistan.

02

Conditions studied

  • Antepartum Hemorrhage
  • Postpartum Hemorrhage
  • Anemia
  • Eclampsia
  • Neonatal Sepsis
  • Birth Asphyxia
  • Diarrhoea
  • Pneumonia
03

In context

Neonatal Sepsis

183 studies on the registry are indexed under Neonatal Sepsis; 41 are open to participants now.

This study's enrollment of 15,000 is above the median of 180 across 95 interventional studies indexed under Neonatal Sepsis.

Browse Neonatal Sepsis studies →

Lead sponsor

Aga Khan University is the lead sponsor of 290 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 49 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be a resident of target areas and consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Do not fulfill the residence and consent criteria
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15,000 participants (actual)

Study arms

  • Experimental
    Intervention Arm

    Antenatal Care, Post natal care, Skilled birth attendance, recognition and referrals of complicated cases, immunization

    Other: Maternal Neonatal and Child Health Interventions

  • No intervention
    Control

    This arm will receive the standard MNCH services as outlined in the MNCH policy of Government of Pakistan

Interventions

  • OtherMaternal Neonatal and Child Health Interventions

    Antenatal care, postnatal care, skilled birth attendance, recognition and referral of complicated cases, immunization

06

What researchers measure

Primary outcomes

  1. Maternal, Neonatal and infant mortality

    A 20% reduction in mortality rates is expected

    Time frame: 24 months

Secondary outcomes

  1. Antenatal Care

    A 40% Increase in Antenatal care is expected

    Time frame: 12 months

  2. Skilled Birth attendance

    A 40% increase in Skilled Birth attendance is expected

    Time frame: 12 months

  3. Essential Neonatal Care

    A 40% increase in uptake of Essential Neonatal Care

    Time frame: 24 months

  4. Child hood Immunization Rates

    A 30% increase in child hood immunization rates

    Time frame: 24 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02797353
Lead sponsor
Aga Khan University
Collaborators
The International Federation of Red Cross and Red Crescent Societies
Responsible party
Dr Sajid Bashir Soofi (Associate Professor, Aga Khan University) — Principal investigator
First posted
Jun 13, 2016
Start date
Jan 2013
Primary completion
Jun 2016
Completion
Aug 2016
Last update
Jun 22, 2020

Study contacts

Sajid Soofi, FCPS
principal investigator · Aga Khan University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion